Login to Your Account



How Foreign Is Too Foreign?

Sort-of Foreigner Could Be Cancer Diagnostic, Target

By Anette Breindl


Wednesday, April 20, 2011
One of the basic ways to classify antibodies is whether they are to self or nonself. But researchers from the University of California, San Diego and start-up Sialix Inc. have identified an antibody that is arguably both – and that might be useful as a cancer diagnostic or therapeutic.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription